表紙:再生医療の世界市場:業界動向、シェア、規模、成長、機会、予測(2022年~2027年)
市場調査レポート
商品コード
1058224

再生医療の世界市場:業界動向、シェア、規模、成長、機会、予測(2022年~2027年)

Regenerative Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 142 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=135.61円
再生医療の世界市場:業界動向、シェア、規模、成長、機会、予測(2022年~2027年)
出版日: 2022年02月12日
発行: IMARC Services Private Limited
ページ情報: 英文 142 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の再生医療の市場規模は、2021年の147億8,000万米ドルから、2027年には504億4,000万米ドルになると予測されており、2022年から2027年までの予測期間中のCAGRは22.6%となっています。

世界中で慢性疾患や遺伝性疾患が増加していることは、市場の成長を促す重要な要因の一つとなっています。また、筋骨格系、腫瘍系、皮膚科系、心臓系など様々な疾患を抱えた高齢者が増加していることも、市場の成長を促しています。これに伴い、臓器移植の普及も市場の成長に寄与しています。さらに、さまざまな技術的進歩も成長を促す要因として作用しています。

当レポートでは、世界の再生医療市場について調査しており、市場概要、市場分析、競合情勢、企業プロファイルなど、包括的な情報を提供しています。

目次

第1章 序文

第2章 範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の再生医療市場

  • 市場概要
  • 市場実績
  • COVID-19の影響

第6章 市場の内訳:タイプ別

  • 幹細胞治療
  • 生体材料
  • ヒト組織工学
  • その他

第7章 市場の内訳:アプリケーション別

  • 骨移植代替物
  • 骨関節疾患
  • 皮膚
  • 心血管
  • 中枢神経系
  • その他

第8章 市場の内訳:エンドユーザー別

  • 病院
  • 専門クリニック
  • その他

第9章 市場の内訳:地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東とアフリカ
    • 市場の内訳:国別

第10章 SWOT分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業プロファイル
    • Allergan PLC(AbbVie Inc.)
    • Amgen Inc.
    • Baxter International Inc.
    • BD(Becton, Dickinson and Company)
    • Integra Lifesciences Holdings Corporation
    • Medtronic Plc
    • Mimedx Group Inc.
    • Novartis AG
    • Osiris Therapeutics Inc.(Smith & Nephew plc)
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Regenerative Medicine Market: Major Drivers and Challenges
  • Figure 2: Global: Regenerative Medicine Market: Sales Value (in Billion US$), 2016-2021
  • Figure 3: Global: Regenerative Medicine Market: Breakup by Type (in %), 2021
  • Figure 4: Global: Regenerative Medicine Market: Breakup by Application (in %), 2021
  • Figure 5: Global: Regenerative Medicine Market: Breakup by End User (in %), 2021
  • Figure 6: Global: Regenerative Medicine Market: Breakup by Region (in %), 2021
  • Figure 7: Global: Regenerative Medicine Market Forecast: Sales Value (in Billion US$), 2022-2027
  • Figure 8: Global: Regenerative Medicine (Stem Cell Therapy) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 9: Global: Regenerative Medicine (Stem Cell Therapy) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 10: Global: Regenerative Medicine (Biomaterial) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 11: Global: Regenerative Medicine (Biomaterial) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 12: Global: Regenerative Medicine (Tissue Engineering) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 13: Global: Regenerative Medicine (Tissue Engineering) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 14: Global: Regenerative Medicine (Other Types) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 15: Global: Regenerative Medicine (Other Types) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 16: Global: Regenerative Medicine (Bone Graft Substitutes) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 17: Global: Regenerative Medicine (Bone Graft Substitutes) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 18: Global: Regenerative Medicine (Osteoarticular Diseases) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 19: Global: Regenerative Medicine (Osteoarticular Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 20: Global: Regenerative Medicine (Dermatology) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 21: Global: Regenerative Medicine (Dermatology) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 22: Global: Regenerative Medicine (Cardiovascular) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 23: Global: Regenerative Medicine (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 24: Global: Regenerative Medicine (Central Nervous System) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 25: Global: Regenerative Medicine (Central Nervous System) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 26: Global: Regenerative Medicine (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 27: Global: Regenerative Medicine (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 28: Global: Regenerative Medicine (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 29: Global: Regenerative Medicine (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 30: Global: Regenerative Medicine (Specialty Clinics) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 31: Global: Regenerative Medicine (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 32: Global: Regenerative Medicine (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 33: Global: Regenerative Medicine (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 34: North America: Regenerative Medicine Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 35: North America: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 36: United States: Regenerative Medicine Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 37: United States: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 38: Canada: Regenerative Medicine Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 39: Canada: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 40: Asia Pacific: Regenerative Medicine Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 41: Asia Pacific: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 42: China: Regenerative Medicine Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 43: China: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 44: Japan: Regenerative Medicine Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 45: Japan: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 46: India: Regenerative Medicine Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 47: India: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 48: South Korea: Regenerative Medicine Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 49: South Korea: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 50: Australia: Regenerative Medicine Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 51: Australia: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 52: Indonesia: Regenerative Medicine Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 53: Indonesia: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 54: Others: Regenerative Medicine Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 55: Others: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 56: Europe: Regenerative Medicine Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 57: Europe: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 58: Germany: Regenerative Medicine Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 59: Germany: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 60: France: Regenerative Medicine Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 61: France: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 62: United Kingdom: Regenerative Medicine Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 63: United Kingdom: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 64: Italy: Regenerative Medicine Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 65: Italy: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 66: Spain: Regenerative Medicine Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 67: Spain: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 68: Russia: Regenerative Medicine Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 69: Russia: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 70: Others: Regenerative Medicine Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 71: Others: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 72: Latin America: Regenerative Medicine Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 73: Latin America: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 74: Brazil: Regenerative Medicine Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 75: Brazil: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 76: Mexico: Regenerative Medicine Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 77: Mexico: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 78: Others: Regenerative Medicine Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 79: Others: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 80: Middle East and Africa: Regenerative Medicine Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 81: Middle East and Africa: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 82: Global: Regenerative Medicine Industry: SWOT Analysis
  • Figure 83: Global: Regenerative Medicine Industry: Value Chain Analysis
  • Figure 84: Global: Regenerative Medicine Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Regenerative Medicine Market: Key Industry Highlights, 2021 and 2027
  • Table 2: Global: Regenerative Medicine Market Forecast: Breakup by Type (in Million US$), 2022-2027
  • Table 3: Global: Regenerative Medicine Market Forecast: Breakup by Application (in Million US$), 2022-2027
  • Table 4: Global: Regenerative Medicine Market Forecast: Breakup by End User (in Million US$), 2022-2027
  • Table 5: Global: Regenerative Medicine Market Forecast: Breakup by Region (in Million US$), 2022-2027
  • Table 6: Global: Regenerative Medicine Market Structure
  • Table 7: Global: Regenerative Medicine Market: Key Players
目次
Product Code: SR0222A79_Report

The global regenerative medicine market reached a value of US$ 14.78 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 50.44 Billion by 2027, exhibiting a CAGR of 22.6% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Regenerative medicine refers to a branch of biomedical sciences aimed at restoring the structure and function of damaged tissues and organs. It involves the utilization of stem cells that are developed in laboratories and further implanted safely into the body for the regeneration of damaged bones, cartilage, blood vessels and organs. Cellular and acellular regenerative medicines are commonly used in various clinical therapeutic procedures, including cell, immunomodulation and tissue engineering therapies. They hold potential for the effective treatment of various chronic diseases, such as Alzheimer's, Parkinson's and cardiovascular disorders (CVDs), osteoporosis and spinal cord injuries.

The increasing prevalence of chronic medical ailments and genetic disorders across the globe is one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is prone to various musculoskeletal, oncological, dermatological and cardiological disorders, is stimulating the market growth. In line with this, widespread adoption of organ transplantation is also contributing to the market growth. Regenerative medicine minimizes the risk of organ rejection by the body post-transplant and enhances the recovery speed of the patient. Additionally, various technological advancements in cell-based therapies, such as the development of 3D bioprinting techniques and the adoption of artificial intelligence (AI) in the production of regenerative medicines, are acting as other growth-inducing factors. These advancements also aid in conducting efficient dermatological grafting procedures to treat chronic burns, bone defects and wounds on the skin. Other factors, including extensive research and development (R&D) activities in the field of medical sciences, along with improving healthcare infrastructure, are anticipated to drive the market further.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global regenerative medicine market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, application and end user.

Breakup by Type:

  • Stem Cell Therapy
  • Biomaterial
  • Tissue Engineering
  • Others

Breakup by Application:

  • Bone Graft Substitutes
  • Osteoarticular Diseases
  • Dermatology
  • Cardiovascular
  • Central Nervous System
  • Others

Breakup by End User:

  • Hospitals
  • Specialty Clinics
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Allergan PLC (AbbVie Inc.), Amgen Inc., Baxter International Inc., BD (Becton, Dickinson and Company), Integra Lifesciences Holdings Corporation, Medtronic plc, Mimedx Group Inc., Novartis AG, Osiris Therapeutics Inc. (Smith & Nephew plc) and Thermo Fisher Scientific Inc. Key Questions Answered in This Report:

  • How has the global regenerative medicine market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global regenerative medicine market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global regenerative medicine market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Regenerative Medicine Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Stem Cell Therapy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Biomaterial
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Tissue Engineering
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Bone Graft Substitutes
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Osteoarticular Diseases
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Dermatology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cardiovascular
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Central Nervous System
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Specialty Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Allergan PLC (AbbVie Inc.)
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Amgen Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Baxter International Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 BD (Becton, Dickinson and Company)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Integra Lifesciences Holdings Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Medtronic Plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Mimedx Group Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Novartis AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Osiris Therapeutics Inc. (Smith & Nephew plc)
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Thermo Fisher Scientific Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis